BDX News - Candlesense

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

Biodesix recently validated Thermo Fisher’s tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer Biodesix recently validated Thermo Fisher’s tissue-based O...

Partnerships

5 days ago

BD to Present at Wells Fargo 2025 Healthcare Conference

FRANKLIN LAKES, N.J., Aug. 14, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fa...

What macro‑economic or regulatory factors might amplify or dampen the market response to BD's announcements at the conference? Could the timing of the presentation (early September) influence analyst sentiment ahead of the Q3 earnings release? What is the expected market reaction to any guidance revisions or earnings forecasts provided during the conference?

Investor events

9 days ago

Flow Cytometry Market worth US$9.85 billion in 2033 with 8.7% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 11, 2025 /PRNewswire/ -- The global Flow Cytometry Market, valued at US$4.87 billion in 2024 stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAG...

How might this market outlook affect supply chain considerations, such as component availability and pricing? Will the increased demand for flow cytometry technology drive higher capital expenditures for manufacturers? What competitive dynamics are expected as the market expands toward $9.85 billion by 2033?

Market

13 days ago

BD Reports Third Quarter Fiscal 2025 Financial Results

Revenue of $5.5 billion increased 10.4% as reported, 8.5% adjusted FXN and 3.0% organic GAAP and adjusted diluted EPS grew to $2.00 and $3.68, respectively GAAP and adjusted gross margin up 160 bas...

How might the company's capital allocation strategy (e.g., dividends, share buybacks, R&D spending) change in response to the strong results? What is the expected impact of this earnings beat on short‑term stock momentum and trading volume? Are there any macro‑economic or currency headwinds that could offset the reported growth in upcoming periods?

Earnings

17 days ago